Apellis Pharmaceuticals
APLS
APLS
210 hedge funds and large institutions have $4.13B invested in Apellis Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 99 increasing their positions, 53 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
0% less funds holding
Funds holding: 211 → 210 (-1)
9% less capital invested
Capital invested by funds: $4.55B → $4.13B (-$420M)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
210
Holding in Top 10
9
Calls
$55.6M
Puts
$22.3M
Top Buyers
| 1 | +$39.9M | |
| 2 | +$36.2M | |
| 3 | +$27.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$26.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$20.7M |
Top Sellers
| 1 | -$121M | |
| 2 | -$52.9M | |
| 3 | -$28.6M | |
| 4 |
Jennison Associates
New York
|
-$18.5M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$12.7M |